Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis

Mauro Gacci1, Giovanni Corona2, Arcangelo Sebastianelli1

  • 1Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

European Urology
|July 25, 2016
PubMed

Insights

Men with moderate to severe lower urinary tract symptoms (LUTS) face a higher risk of major adverse cardiac events (MACE). This highlights the importance of considering LUTS as a significant cardiovascular risk factor in men.

Area of Science:

  • Cardiology
  • Urology
  • Public Health

Background:

  • The link between metabolic syndrome, lower urinary tract symptoms (LUTS), and cardiovascular disease (CVD) is established.
  • Cardiovascular disease (CVD) is a potential risk factor for LUTS progression and severity.

Purpose of the Study:

  • To determine if LUTS severity is a significant risk factor for major adverse cardiac events (MACE) in men.
  • To evaluate the association between LUTS and cardiovascular risk in the male population.

Main Methods:

  • A systematic literature search was conducted across PubMed, Google Scholar, and Scopus.
  • Keywords included "benign prostatic hyperplasia" or "lower urinary tract symptoms" combined with cardiovascular terms.
  • Included cross-sectional and longitudinal studies comparing MACE incidence/prevalence in men with moderate-to-severe LUTS versus those with mild or no LUTS.

Main Results:

  • Meta-analysis of 10 cross-sectional studies (38,218 men) showed moderate-to-severe LUTS significantly increased the risk of a history of MACE (p<0.001).
  • Metaregression indicated LUTS-related MACE risk was lower in older patients but higher in those with diabetes.
  • Longitudinal analysis of 5 studies (25,494 men) revealed moderate-to-severe LUTS was associated with increased MACE incidence (OR: 1.68; 95% CI, 1.13-2.50; p=0.01).

Conclusions:

  • Moderate to severe LUTS in men is linked to an elevated risk of MACE.
  • A comprehensive approach to aging men's health, integrating urological and cardiovascular assessments, is recommended.
  • Urologists play a crucial role in identifying and managing cardiovascular risk in patients with LUTS.
Abstract

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...